153 related articles for article (PubMed ID: 6155612)
1. Influence of preimmunization antibody levels on the specificity of the immune response to related polysaccharide antigens.
Baker CJ; Kasper DL; Edwards MS; Schiffman G
N Engl J Med; 1980 Jul; 303(4):173-8. PubMed ID: 6155612
[TBL] [Abstract][Full Text] [Related]
2. Immunization of pregnant women with a polysaccharide vaccine of group B streptococcus.
Baker CJ; Rench MA; Edwards MS; Carpenter RJ; Hays BM; Kasper DL
N Engl J Med; 1988 Nov; 319(18):1180-5. PubMed ID: 3050524
[TBL] [Abstract][Full Text] [Related]
3. Pneumococcal polysaccharide immunization of children with sickle cell disease. II. Serologic response and pneumococcal disease following immunization.
Overturf GD; Selzer JW; Chan L; Weiss J; Field R; Rigau-Perez JG; Powars D; Uy C; Pang EJ; Honig G; Steele R; Edmonds R; Portnoy B
Am J Pediatr Hematol Oncol; 1982; 4(1):25-35. PubMed ID: 7091574
[TBL] [Abstract][Full Text] [Related]
4. Immunization of humans with polysaccharide vaccines induces systemic, predominantly polymeric IgA2-subclass antibody responses.
Tarkowski A; Lue C; Moldoveanu Z; Kiyono H; McGhee JR; Mestecky J
J Immunol; 1990 May; 144(10):3770-8. PubMed ID: 2110213
[TBL] [Abstract][Full Text] [Related]
5. Kinetics of the antibody response to type III pneumococcal polysaccharide (SSS-III). I. Use of 125I-labeled SSS-III to study serum antibody levels, as well as the distribution and excretion of antigen after immunization.
Jones JM; Amsbaugh DF; Prescott B
J Immunol; 1976 Jan; 116(1):41-51. PubMed ID: 1445
[TBL] [Abstract][Full Text] [Related]
6. Kinetics of the antibody response to type III pneumococcal polysaccharide. II. Factors influencing the serum antibody levels after immunization with an optimally immunogenic dose of antigen.
Jones JM; Amsbaugh DF; Prescott B
J Immunol; 1976 Jan; 116(1):52-64. PubMed ID: 1446
[TBL] [Abstract][Full Text] [Related]
7. Preimmunization and postimmunization pneumococcal antibody titers in children with recurrent infections.
Hidalgo H; Moore C; Leiva LE; Sorensen RU
Ann Allergy Asthma Immunol; 1996 Apr; 76(4):341-6. PubMed ID: 8612116
[TBL] [Abstract][Full Text] [Related]
8. Immunodeterminant specificity of human immunity to type III group B streptococcus.
Kasper DL; Baker CJ; Baltimore RS; Crabb JH; Schiffman G; Jennings HJ
J Exp Med; 1979 Feb; 149(2):327-39. PubMed ID: 84042
[TBL] [Abstract][Full Text] [Related]
9. In vivo and in vitro humoral immunity in surgical patients: antibody response to pneumococcal polysaccharide.
Nohr CW; Latter DA; Meakins JL; Christou NV
Surgery; 1986 Aug; 100(2):229-38. PubMed ID: 3488597
[TBL] [Abstract][Full Text] [Related]
10. Response to type III polysaccharide in women whose infants have had invasive group B streptococcal infection.
Baker CJ; Rench MA; Kasper DL
N Engl J Med; 1990 Jun; 322(26):1857-60. PubMed ID: 2190087
[No Abstract] [Full Text] [Related]
11. Role of antibody to native type III polysaccharide of group B Streptococcus in infant infection.
Baker CJ; Edwards MS; Kasper DL
Pediatrics; 1981 Oct; 68(4):544-9. PubMed ID: 7033911
[TBL] [Abstract][Full Text] [Related]
12. Pneumococcal polysaccharide immunization in infants and children.
Cowan MJ; Ammann AJ; Wara DW; Howie VM; Schultz L; Doyle N; Kaplan M
Pediatrics; 1978 Nov; 62(5):721-7. PubMed ID: 31592
[TBL] [Abstract][Full Text] [Related]
13. Distinct approaches to investigate the importance of the murine 4-1BB 4-1BBL interaction in the antibody response to Streptococcus pneumoniae.
Moens L; Jeurissen A; Mittler RS; Wuyts G; Michiels G; Boon L; Ceuppens JL; Bossuyt X
J Leukoc Biol; 2007 Sep; 82(3):638-44. PubMed ID: 17550973
[TBL] [Abstract][Full Text] [Related]
14. Pneumococcal polysaccharide immunization of children with sickle cell disease. I. Clinical reactions to immunization and relationship to preimmunization antibody.
Overturf GD; Rigau-Perez JG; Selzer J; Field RJ; Powars D; Pang EJ; Uy C; Honig G; Weiss J; Chan L; Portnoy B
Am J Pediatr Hematol Oncol; 1982; 4(1):19-23. PubMed ID: 7091573
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity of polysaccharides from type III, group B Streptococcus.
Baker CJ; Edwards MS; Kasper DL
J Clin Invest; 1978 Apr; 61(4):1107-10. PubMed ID: 96132
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the cellular immune response following in vivo immunization with pneumococcal polysaccharides in man.
Kehrl JH; Fauci AS
Bull Eur Physiopathol Respir; 1983; 19(2):227-34. PubMed ID: 6347283
[TBL] [Abstract][Full Text] [Related]
17. Effect of anesthesia and splenectomy on antibody response to pneumococcal polysaccharide immunization.
Barringer M; Meredith W; Sterchi M; Schiffman G; Meredith J; Beyer F
Am Surg; 1982 Dec; 48(12):628-33. PubMed ID: 7158858
[TBL] [Abstract][Full Text] [Related]
18. Correlation between serum IgG-2 concentrations and the antibody response to bacterial polysaccharide antigens.
Siber GR; Schur PH; Aisenberg AC; Weitzman SA; Schiffman G
N Engl J Med; 1980 Jul; 303(4):178-82. PubMed ID: 6966763
[TBL] [Abstract][Full Text] [Related]
19. Models for assessing the effect of toxicants on immunocompetence in mice. II. Effect of cyclophosphamide on the antibody responses to type III pneumococcal polysaccharide and tetanus toxoid in BALB/c female mice.
Speirs RS; Benson RW; Knowles BJ; Roberts D
J Environ Pathol Toxicol; 1978; 1(6):791-812. PubMed ID: 32218
[TBL] [Abstract][Full Text] [Related]
20. Impaired antibody response to pneumococcal vaccine after treatment for Hodgkin's disease.
Siber GR; Weitzman SA; Aisenberg AC; Weinstein HJ; Schiffman G
N Engl J Med; 1978 Aug; 299(9):442-8. PubMed ID: 28483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
